Drug Profile
Research programme: companion diagnostics - Stemergie Biotechnology
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Stemergie Biotechnology
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glioma
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Glioma(Diagnosis) in Switzerland
- 10 Aug 2016 Early research in Glioma (Diagnosis) in Switzerland (unspecified route)